Regeneron Pharmaceuticals, Inc.
2018 Q1 - 2025 Q4 (32 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/22/2026 | 279 | 0.0% | 361 | 12/31/2025 |
| 2025 Q3 | 10/9/2025 | 203 | 0.0% | 361 | 9/30/2025 |
| 2025 Q2 | 7/18/2025 | 182 | 0.0% | 347 | 6/30/2025 |
| 2025 Q1 | 4/24/2025 | 218 | 0.0% | 344 | 3/31/2025 |
| 2024 Q4 | 1/17/2025 | 245 | 0.0% | 344 | 12/31/2024 |
| 2024 Q3 | 10/17/2024 | 362 | 0.0% | 344 | 9/30/2024 |
| 2024 Q2 | 7/12/2024 | 362 | 0.0% | 344 | 6/30/2024 |
| 2024 Q1 | 5/9/2024 | 333 | 0.0% | 346 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 303 | 0.0% | 344 | 12/31/2023 |
| 2023 Q3 | 2/14/2024 | 283 | 0.0% | 344 | 9/30/2023 |
| 2023 Q2 | 2/14/2024 | 247 | 0.0% | 344 | 6/30/2023 |
| 2023 Q1 | 2/14/2024 | 283 | 0.0% | 344 | 3/31/2023 |
| 2022 Q4 | 2/14/2024 | 248 | 0.0% | 344 | 12/31/2022 |
| 2022 Q3 | 2/14/2024 | 237 | 0.0% | 344 | 9/30/2022 |
| 2022 Q2 | 2/14/2024 | 203 | 0.0% | 344 | 6/30/2022 |
| 2022 Q1 | 2/14/2024 | 240 | 0.0% | 344 | 3/31/2022 |
| 2021 Q4 | 2/14/2024 | 217 | 0.0% | 344 | 12/31/2021 |
| 2021 Q3 | 2/14/2024 | 208 | 0.0% | 344 | 9/30/2021 |
| 2021 Q2 | 2/14/2024 | 197 | 0.0% | 353 | 6/30/2021 |
| 2021 Q1 | 2/14/2024 | 167 | 0.0% | 353 | 3/31/2021 |
| 2020 Q4 | 2/13/2024 | 171 | 0.0% | 353 | 12/31/2020 |
| 2020 Q3 | 2/13/2024 | 193 | 0.0% | 344 | 9/30/2020 |
| 2020 Q2 | 2/13/2024 | 215 | 0.0% | 344 | 6/30/2020 |
| 2020 Q1 | 2/13/2024 | 102 | 0.0% | 209 | 3/31/2020 |
| 2019 Q4 | 2/13/2024 | 78 | 0.0% | 209 | 12/31/2019 |
| 2019 Q3 | 2/13/2024 | 58 | 0.0% | 209 | 9/30/2019 |
| 2019 Q2 | 2/13/2024 | 13 | 0.0% | 41 | 6/30/2019 |
| 2019 Q1 | 2/13/2024 | 16 | 0.0% | 40 | 3/31/2019 |
| 2018 Q4 | 2/13/2024 | 15 | 0.0% | 40 | 12/31/2018 |
| 2018 Q3 | 2/13/2024 | 16 | 0.0% | 40 | 9/30/2018 |
| 2018 Q2 | 2/13/2024 | 14 | 0.0% | 40 | 6/30/2018 |
| 2018 Q1 | 2/13/2024 | 14 | 0.0% | 40 | 3/31/2018 |